Skip to main content

Table 1 Baseline demographics

From: Short-term aspirin and statin chemoprophylaxis did not reduce the risk of developing advanced adenomatous polyps in Black patients

Advanced adenomatous polyp on subsequent colonoscopy?
Variables   No (number/percent) Yes (number/percent) p-value
Sex Female 411 (55.09) 108 (47.79) 0.05
  Male 335 (44.91) 118 (52.21)  
Statin use No 221 (42.02) 41 (33.88) 0.10
  Yes 305 (57.98) 80 (66.12)  
Tobacco use Never 250 (33.88) 58 (25.89) < 0.001
  Quit 249 (33.74) 109 (48.66)  
  Yes 239 (32.38) 57 (25.45)  
Aspirin use No 252 (33.78) 79 (34.96) 0.74
  Yes 494 (66.22) 147 (65.04)  
Documented race Black/African-American 641 (85.92) 185 (81.86) 0.13
  Non-Black 105 (14.08) 41 (18.14)  
Statin and aspirin use Both 236 (51.98) 59 (55.66) 0.56
  Part/None 218 (48.02) 47 (44.34)  
Age at first colonoscopy   59.04 (8.99) 59.54 (8.05) 0.43
Body mass index   30.21 (7.17) 31.26 (7.49) 0.07